 
 
Prominent pro-Crypto attorney Bill Morgan is shutting down claims that Ripple’s native token XRP, the third-largest cryptocurrency by market cap, has no use case.
The altcoin, like many others, has been reportedly criticized and branded as inferior to the leading cryptocurrency Bitcoin, especially by Bitcoin maximalists, but Morgan is attempting to put the critics to sleep.
In a detailed post shared on X, Bill Morgan, who is most outspoken about Ripple and XRP-related topics, is once again throwing his weight behind the XRP token.
This time, Morgan is responding directly to market onlookers, sure that the XRP token has no intrinsic value—a sentiment that many crypto players have touted.
The analyst points to Wellgistics Health’s S11 form filed with the SEC, in which the healthcare technology and pharmaceutical logistics company disclosed its extensive use of the XRP token.
 
As Bill Morgan shared, the health-tech company, founded in 2022, disclosed that the XRP token will be added to its treasury reserve.
In the long term, Wellgistics Health intends to leverage the XRP ledger through the integration of a payment solution. The solution is designed to facilitate affordable real-time payments between the Health tech platform, its manufacturers, pharmacy customers, and gender partners.
Extending its use of XRP into the future, the tech firm revealed plans to issue equity or debt securities, with the sole aim of purchasing more XRP tokens with the proceeds. The firm stated its intentions to utilize its XRP holdings as collateral for capital raising transactions and the creation of new income streams.
Conclusively, Bill Morgan noted the broader significance of Wellgistics Health’s filing, saying;
“In short, using XRP as a reserve asset, to earn income, to use it as collateral and use it for payments all in one. XRP will be working hard for WH. But they say XRP has no utility.”